PASCAL SORIOT LEADERSHIP
AstraZeneca 'magic' faces rare test after trial failure, share slideAstraZeneca's nerve drug Wainua unexpectedly failed a late-stage heart disease trial. This setback has caused investor concern and impacted...
Trump may try to force drugmakers to lower some U.S. pricesThe Trump administration is considering a regulatory approach to lower U.S. drug prices, potentially aligning them with those of other weal...
EU begins vaccinations to end Covid 'nightmare'The jab is a glimmer of hope for a continent yearning for a return to normal from a pandemic that has killed 1.76 million people worldwide ...
Coronavirus-triggered layoffs in US hit nearly 39 millionAn additional 2.2 million sought aid under a new federal program for self-employed, contractor and gig workers, who are now eligible for un...
Load More